Evidence map›Paper›PMID 35820291›Full record

ArticleDrug and alcohol dependence2022

A latent class analysis of tailored substance use treatment programs: Implications for treating syndemic conditions facing sexual and gender minority populations.

Emily C Helminen, Cory J Cascalheira, Thomas J Shaw, Sarah Zollweg, Tonda L Hughes, Jillian R Scheer

Open access · greenAbstract read
In one paragraph

Article in Drug and alcohol dependence, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Emily C HelminenDepartment of Psychology, Syracuse University, Syracuse, NY, USA.
Cory J CascalheiraDepartment of Psychology, Syracuse University, Syracuse, NY, USA; Department of Counseling and Educational Psychology, New Mexico State University, Las Cruces, NM, USA.
Thomas J ShawDepartment of Psychology, Syracuse University, Syracuse, NY, USA.
Sarah ZollwegSchool of Nursing, Columbia University, New York, NY, USA.
Tonda L HughesSchool of Nursing, Columbia University, New York, NY, USA; Department of Psychiatry, Columbia University, New York, NY, USA.
Jillian R ScheerDepartment of Psychology, Syracuse University, Syracuse, NY, USA. Electronic address: jrscheer@syr.edu.
Syracuse University · USColumbia University · US

Funding

RISE PROGRAM AT NEW MEXICO STATE UNIVERSITYR25GM061222 · NIGMS · NEW MEXICO STATE UNIVERSITY LAS CRUCES · PI HOUSTON, JESSICA PEREA, REDDI, LAKSHMI · 2000 to 2022
$21.3M
Impact of supportive policies on minority stress, drinking and health among womenR01AA013328 · NIAAA · UNIVERSITY OF ILLINOIS AT CHICAGO · PI HUGHES, TONDA L, MATTHEWS, ALICIA K · 2002 to 2021
$8.0M
Testing a Biopsychosocial Model of Violence Exposure, Minority Stressors, and Hazardous Drinking among Sexual Minority WomenK01AA028239 · NIAAA · UNIVERSITY OF RHODE ISLAND · PI SCHEER, JILLIAN R · 2021 to 2025
$1.0M
The Influence of Multilevel Minority Stress on Hazardous Drinking among Sexual Minority WomenF31AA029847 · NIAAA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ZOLLWEG, SARAH · 2021 to 2022
$85k
NIAAA NIH HHS F31 AA029847NIAAA NIH HHS K01 AA028239NIAAA NIH HHS R01 AA013328NIGMS NIH HHS R25 GM061222
6 · The paper itself

Abstract

backgroundSyndemics (i.e., multiple, co-occurring, and synergistic conditions) contribute to elevated substance use among sexual and gender minority (SGM) people relative to heterosexual, cisgender people. Research suggests that syndemic-informed and SGM-tailored treatments are effective in substance use treatment among SGM people. However, few studies have examined 1) the proportion of substance use treatment facilities offering syndemic-informed, SGM-tailored treatment programming; and 2) the availability and accessibility of syndemic-informed, SGM-tailored treatment programs across the U.S.

methodsWe used the 2020 National Survey of Substance Abuse Treatment Services (N-SSATS) dataset to perform a latent class analysis examining whether substance use treatment facilities' tailored treatment programs cluster together to form distinct classes indicating whether facilities offer syndemic-informed and SGM-tailored programming. We then used multinomial logistic regression to examine associations between class membership and facility availability and accessibility.

resultsAnalyses revealed four classes of substance use treatment facilities' tailored programs. Facilities with syndemic-informed and SGM-tailored treatment programs compared to facilities with no tailored programs were more likely to be in the Northeast compared to the Midwest and South; to offer payment assistance versus not offer payment assistance; and to be private, for-profit facilities versus public or non-profit facilities.

conclusionsThis study's findings identify the need for more facilities with syndemic-informed and SGM-tailored treatment, particularly in the Midwestern and Southern U.S. regions. Facilities offering syndemic-informed and SGM-tailored treatment might present accessibility barriers for low-income SGM people, as they were more likely to be private, for-profit facilities; however, they were more likely to offer payment assistance.

Indexed as

Sexual and Gender MinoritiesSubstance-Related DisordersHumansLatent Class AnalysisSexual BehaviorSyndemicGender minoritySexual minoritySubstance useSyndemic theoryTreatment facilities

Identifiers

PMID35820291
PMCPMC9444885
OpenAlexW4283727736

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.